Copy For Citation
İÇLİ F., Altundag K., AKBULUT H., PAYDAŞ S., Basaran G., Saip P., ...More
BREAST CANCER, vol.22, no.5, pp.480-485, 2015 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
22
Issue:
5
-
Publication Date:
2015
-
Doi Number:
10.1007/s12282-013-0506-y
-
Journal Name:
BREAST CANCER
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.480-485
-
Çukurova University Affiliated:
Yes
Abstract
Background Optimal duration of adjuvant trastuzumab in early breast cancer is an unresolved issue. In this observational study, we compared the outcome of 9 weeks and 1 year adjuvant trastuzumab in early breast cancer patients in Turkey.